Advanced Code injection
0
Skip to Content
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
OBIO - Ontario Bioscience Innovation Organization
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
All Events
OBIO Investment Summit
News & Press Releases
Tariff Relief Resources
Membership
Member Log in
Job Board
Folder: About
Back
About OBIO
Governance
OBIO Team
Our Partners
Contact Us
Folder: Areas of Focus
Back
At a Glance
Capital Access & Adoption
Skills Development & Training
Women in Health Initiative
Critical Technologies
Advocacy Efforts
Folder: Events
Back
All Events
OBIO Investment Summit
Folder: News
Back
News & Press Releases
Tariff Relief Resources
Folder: Membership
Back
Membership
Member Log in
Job Board
Ontario Industry Updates, OBIO News Arsheen Kaur 4/2/24 Ontario Industry Updates, OBIO News Arsheen Kaur 4/2/24

Flosonics Medical secures $20 million USD in Series C funding

Read More
Press Releases, OBIO News Doriane Rey 3/26/24 Press Releases, OBIO News Doriane Rey 3/26/24

Through OBIO’s EAHN™, Trexo Plus Robotic Walker Enables Children with Physical Disabilities to Achieve Personalized Rehabilitation

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Quthero secures $500,000 investment boost from the Ontario Centre of Innovation

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Noa Therapeutics secures pre-Seed financing to transform the treatment of inflammatory disease

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Fusion Pharmaceuticals to be acquired by AstraZeneca, accelerating development of next-generation radioconjugates to treat cancer

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Domain Therapeutics and Chime Biologics join forces to advance novel anti-CCR8 antibody for cancer immunotherapy

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/19/24

Cosm Medical achieves FDA clearance for Gynethotics™ Pessaries, pioneering the future of personalized pelvic care

Read More
OBIO News, Press Releases Doriane Rey 3/14/24 OBIO News, Press Releases Doriane Rey 3/14/24

OBIO® Celebrates International Women’s Day with Investment in Three Women-Led Companies and a Successful Graduation of First Seed Funding Cohort

Read More
OBIO News, Press Releases Doriane Rey 3/8/24 OBIO News, Press Releases Doriane Rey 3/8/24

FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program

Read More
OBIO News, Press Releases Doriane Rey 3/5/24 OBIO News, Press Releases Doriane Rey 3/5/24

A Light at the End of the Toenail

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24

Tenomix secures an all-Canadian oversubscribed Seed round of $2M to advance a breakthrough cancer care robotics system

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24

Canadian technology that could transform how we treat cancer

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24 Ontario Industry Updates, OBIO News Arsheen Kaur 3/5/24

HDAX among ten exciting U of T-affiliated start-ups to keep an eye on in 2024

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24 Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24

More recognition for OBIO® member Vena Medical

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24 Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24

MIMOSA Diagnostics receives Health Canada approval

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24 Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24

Mediphage Bioceuticals closes Seed round financing

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24 Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24

KA Imaging to present on Portable Dual-Energy Tomosynthesis at ECR 2024

Read More
Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24 Ontario Industry Updates, OBIO News Arsheen Kaur 2/21/24

Eurofins CDMO Alphora announces the completion of a new pilot scale biologics development facility

Read More
Press Releases, OBIO News Doriane Rey 2/21/24 Press Releases, OBIO News Doriane Rey 2/21/24

The OBIO® Investment Summit reaches new heights, drawing the attention of international capital to Canadian healthcare innovations

Read More
Newer Posts
Older Posts
Become an OBIO® Member Today!

Contact us:

OBIO®
101 College St., Suite HL50

Toronto, ON M5G 1L7

OBIO © 2025

(416) 848 6839
info@obio.ca

Media Kit

NEWSlETTER Sign UP

Terms & Conditions